Literature DB >> 27919508

The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis.

Mohammad Abdoli1, Santanu Chakraborty2, Heather J MacLean3, Mark S Freedman4.   

Abstract

BACKGROUND: Gadolinium (Gd) enhancement of lesions is the main radiologic marker for detection of activity in Multiple Sclerosis (MS). This study compares Diffusion weighted imaging (DWI) characteristics and enhancement to determine whether DWI can be used as an alternative to Gd administration.
METHODS: A retrospective study of 72 patients who had MRI with Gd and DWI. Visual assessment and comparison of the Apparent Diffusion Coefficient (ADC) values on Gd+ lesions, all lesions showing restricted diffusion, 2 Gd- lesions and 1 area of normal-appearing white matter (NAWM) in each MRI were performed.
RESULTS: DWI values were measured on 275 T2 lesions, 68 Gd+ and 207 Gd- lesions, as well as 104 NAWM. 34 Gd+ lesions showed restricted diffusion. The median ADC-minimum of Gd+ lesions was significantly lower than NAWM and even lower than Gd- lesions. Most DWI restricted lesions were also Gd+(specificity≥94%), however many Gd+ lesions did not show visually detectable restriction in DWI (sensitivity≤34%). The median ADC-minimum of symptomatic lesions was lower than asymptomatic lesions.
CONCLUSION: While Gd+ lesions have lower ADC-minimum, visual DWI assessment cannot replace Gd administration for identifying active lesions. Gd+ lesions showing restricted diffusion are clinically important as they are more likely associated with neurological symptoms. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Detection of new MRI activity; Diffusion magnetic resonance imaging; Gadolinium; Magnetic resonance imaging; Multiple sclerosis; Restricted diffusion

Mesh:

Substances:

Year:  2016        PMID: 27919508     DOI: 10.1016/j.msard.2016.09.006

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  6 in total

Review 1.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

Review 2.  Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.

Authors:  Suradech Suthiphosuwan; David Kim; Aditya Bharatha; Jiwon Oh
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

3.  Diffusion-derived parameters in lesions, peri-lesion and normal-appearing white matter in multiple sclerosis using tensor, kurtosis and fixel-based analysis.

Authors:  Chris Wj van der Weijden; Anouk van der Hoorn; Jan Hendrik Potze; Remco J Renken; Ronald Jh Borra; Rudi Ajo Dierckx; Ingomar W Gutmann; Hakim Ouaalam; Davood Karimi; Ali Gholipour; Simon K Warfield; Erik Fj de Vries; Jan F Meilof
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-25       Impact factor: 6.960

4.  Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.

Authors:  Caroline Guglielmetti; Chloé Najac; Alessandro Didonna; Annemie Van der Linden; Sabrina M Ronen; Myriam M Chaumeil
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

5.  Is It Possible to Discriminate Active MS Lesions with Diffusion Weighted Imaging?

Authors:  Sena Unal; Elif Peker; Seyda Erdogan; Memet Ilhan Erden
Journal:  Eurasian J Med       Date:  2019-10

6.  Different MRI patterns in MS worsening after stopping fingolimod.

Authors:  Caterina Lapucci; Damiano Baroncini; Maria Cellerino; Giacomo Boffa; Ilaria Callegari; Matteo Pardini; Giovanni Novi; Maria Pia Sormani; Giovanni Luigi Mancardi; Angelo Ghezzi; Mauro Zaffaroni; Antonio Uccelli; Matilde Inglese; Luca Roccatagliata
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.